Utilize este identificador para referenciar este registo:
https://hdl.handle.net/1822/77376
Título: | Paying for pharmaceuticals: uniform pricing versus two-part tariffs |
Autor(es): | Brekke, Kurt R. Dalen, Dag Morten Straume, Odd Rune |
Palavras-chave: | Health plans Payment schemes Pharmaceuticals |
Data: | 2022 |
Editora: | Elsevier 1 |
Revista: | Journal of Health Economics |
Resumo(s): | Two-part pricing (the Netflix model) has recently been proposed instead of uniform pricing for pharmaceuticals. Under two-part pricing the health plan pays a fixed fee for access to a drug at unit prices equal to marginal costs. Despite two-part pricing being socially efficient, we show that the health plan is worse off when the drug producer is a monopolist, as all surplus is extracted. This result is reversed with competition, as two-part pricing yields higher patient utility and lower drug costs for the health plan. However, if we allow for exclusive contracts, uniform pricing is preferred by the health plan. The choice of payment scheme is also shown to influence on the incentives to spend resources on drastic innovations relative to incremental, me-too innovations. |
Tipo: | Artigo |
URI: | https://hdl.handle.net/1822/77376 |
DOI: | 10.1016/j.jhealeco.2022.102613 |
ISSN: | 0167-6296 |
Versão da editora: | https://www.sciencedirect.com/science/article/pii/S0167629622000339 |
Arbitragem científica: | yes |
Acesso: | Acesso embargado (2 Anos) |
Aparece nas coleções: | EEG - Artigos em revistas de circulação internacional com arbitragem científica |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
DrugPricingFinal_merged.pdf Até 2025-01-01 | 463,1 kB | Adobe PDF | Ver/Abrir |